Regulation of the Wnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma: Mechanisms, Translational Relevance, and Therapeutic Implications
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.081222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Chao Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Hospital & Second Clinical Medical College, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, RNA, Untranslated. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Esophageal Squamous Cell Carcinoma (ESCC) is a highly aggressive malignancy characterized by a poor long-term prognosis. Aberrant activation of the canonical Wnt/β-catenin pathway serves as a central oncogenic driver in ESCC, with large-scale genomic analyses revealing that most patients harbor alterations in pathway-associated genes. This signaling axis orchestrates a wide array of malignant phenotypes, including tumor proliferation, invasion, epithelial-mesenchymal transition (EMT), cancer stemness, and therapeutic resistance. Therefore, this review aims to provide a comprehensive synthesis of the multifaceted crosstalk between various ncRNA classes and the Wnt/β-catenin axis, highlighting their roles in ESCC progression and their potential as mechanism-based clinical tools. Emerging evidence identifies non-coding RNAs (ncRNAs)-including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)-as key regulators of this pathway in ESCC. In this article, we systematically summarize the molecular mechanisms by which 36 unique ncRNA species (20 miRNAs, 10 lncRNAs, and 6 circRNAs) modulate Wnt signaling. Oncogenic ncRNAs promote malignant progression by suppressing negative regulators within complex competing endogenous RNA (ceRNA) networks, whereas tumor-suppressive ncRNAs inhibit pathway activation by targeting Wnt ligands, receptors, or downstream effectors. Furthermore, we discuss the translational relevance of ncRNA-based biomarkers for risk stratification and prognosis in clinical cohorts. Finally, we evaluate pharmacological strategies for ncRNA-based therapeutics while highlighting critical challenges related to delivery efficiency, specificity, molecular stability, off-target effects, tumor heterogeneity, and clinical validation. Ultimately, a clearer understanding of the ncRNA-Wnt regulatory network is essential for developing personalized, mechanism-based diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Hospital & Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Zitieren
APA
Han, C., Hou, M., Yang, R., Wei, X., & Wang, C. (2026). Regulation of the Wnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma: Mechanisms, Translational Relevance, and Therapeutic Implications. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.081222
Vancouver
Han C, Hou M, Yang R, Wei X, Wang C. Regulation of the Wnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma: Mechanisms, Translational Relevance, and Therapeutic Implications. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.081222
BibTeX
@article{Han2026,
author = {Han, Chao and Hou, Ming and Yang, Ruifeng and Wei, Xiaoping and Wang, Cheng},
title = {Regulation of the Wnt/β-Catenin Signaling Pathway by Non-Coding RNAs in Esophageal Squamous Cell Carcinoma: Mechanisms, Translational Relevance, and Therapeutic Implications},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.081222}
}
EUVIMED